Carb-Blocking Supplement Marketers Served With FDA Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplements that make unsubstantiated carb-blocking claims are targeted by FDA in eight recent warning letters
You may also be interested in...
Pharmachem Gains Phase 2 Claims Agreement, Plus Patent For New Product
Pharmachem Laboratories' experience with claims for its Phase 2 starch-neutralizer branded ingredient may provide an example for firms seeking to validate claims with the FDA, the firm says
Pharmachem Gains Phase 2 Claims Agreement, Plus Patent For New Product
Pharmachem Laboratories' experience with claims for its Phase 2 starch-neutralizer branded ingredient may provide an example for firms seeking to validate claims with the FDA, the firm says
Pharmachem Gains Phase 2 Claims Agreement, Plus Patent For New Product
Pharmachem Laboratories' experience with claims for its Phase 2 starch-neutralizer branded ingredient may provide an example for firms seeking to validate claims with the FDA, the firm says